Page last updated: 2024-10-26

dimercaprol and Infectious Diseases

dimercaprol has been researched along with Infectious Diseases in 8 studies

Dimercaprol: An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.
dimercaprol : A dithiol that is propane-1,2-dithiol in which one of the methyl hydrogens is replaced by a hydroxy group. a chelating agent originally developed during World War II as an experimental antidote against the arsenic-based poison gas Lewisite, it has been used clinically since 1949 for the treatment of poisoning by arsenic, mercury and gold. It can also be used for treatment of poisoning by antimony, bismuth and possibly thallium, and (with sodium calcium edetate) in cases of acute leaad poisoning. Administration is by (painful) intramuscular injection of a suspension of dimercaprol in peanut oil, typically every 4 hours for 2-10 days depending on the toxicity. In the past, dimercaprol was also used for the treatment of Wilson's disease, a severely debilitating genetic disorder in which the body tends to retain copper, with resultant liver and brain injury.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GROS, H2
KIRNBERGER, EJ2
JAKOBIEC, M1
KRAUSS-ZAKI, J1
FISCHER, PS2
POPESCU, IG2
SAPOSNIC, A2
SIMIONOVICI, B2
RACHON, K1
JANUSZKIEWICZ, J1
BRAUN, G1
KORTGE, P1
BAUFELD, H1
CREATURO, NE1

Other Studies

8 other studies available for dimercaprol and Infectious Diseases

ArticleYear
[Effect of BAL on glutathione blood level in hepatitis epidemica].
    Klinische Wochenschrift, 1952, Jul-15, Volume: 30, Issue:27-28

    Topics: Communicable Diseases; Dimercaprol; Glutathione; Hepatitis; Hepatitis A; Humans; Viral Vaccines

1952
[Changes of the iodometrically determined reduced glutathion during hepatitis; the effects of BAL on it].
    Zeitschrift fur klinische Medizin, 1952, Volume: 150, Issue:1

    Topics: Communicable Diseases; Dimercaprol; Glutathione; Hepatitis; Hepatitis A

1952
[Treatment of parenchymatous jaundice with BAL].
    Polski tygodnik lekarski, 1954, Jun-28, Volume: 9, Issue:26

    Topics: Communicable Diseases; Dimercaprol; Hepatitis; Hepatitis A; Jaundice

1954
[Trial therapy of epidemic hepatitis].
    Probleme de tuberculoza, 1956, Volume: 3

    Topics: Communicable Diseases; Corrinoids; Dimercaprol; Hepatitis; Hepatitis A; Humans; Mineral Waters; Vita

1956
[Trial therapy of epidemic hepatitis].
    Probleme de tuberculoza, 1956, Volume: 3

    Topics: Communicable Diseases; Corrinoids; Dimercaprol; Hepatitis; Hepatitis A; Humans; Mineral Waters; Vita

1956
[Trial therapy of epidemic hepatitis].
    Probleme de tuberculoza, 1956, Volume: 3

    Topics: Communicable Diseases; Corrinoids; Dimercaprol; Hepatitis; Hepatitis A; Humans; Mineral Waters; Vita

1956
[Trial therapy of epidemic hepatitis].
    Probleme de tuberculoza, 1956, Volume: 3

    Topics: Communicable Diseases; Corrinoids; Dimercaprol; Hepatitis; Hepatitis A; Humans; Mineral Waters; Vita

1956
[Evaluation of the treatment of epidemic hepatitis with dithiopropanol (BAL)].
    Polski tygodnik lekarski, 1958, Mar-31, Volume: 13, Issue:13

    Topics: Communicable Diseases; Dimercaprol; Epidemics; Hepatitis; Hepatitis A

1958
[Comparative studies on the effect of 2,3-dithiopropanol (BAL) on the course of acute viral hepatitis].
    Arztliche Wochenschrift, 1955, Mar-25, Volume: 10, Issue:12

    Topics: Communicable Diseases; Dimercaprol; Hepatitis; Hepatitis A; Viral Vaccines

1955
[BAL and iron metabolism in infectious hepatitis].
    Zeitschrift fur arztliche Fortbildung, 1955, Mar-01, Volume: 49, Issue:5

    Topics: Blood; Communicable Diseases; Dimercaprol; Hepatitis; Hepatitis A; Iron; Viral Vaccines

1955
Infectious mononucleosis and polyneuritis (Guillain-Barré syndrome); report of a case of facial diplegia treated with 2,3 dimercaptopropanol (BAL).
    Journal of the American Medical Association, 1950, May-20, Volume: 143, Issue:3

    Topics: Communicable Diseases; Dimercaprol; Guillain-Barre Syndrome; Humans; Infectious Mononucleosis; Neuri

1950